| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.893 | 9.166 | 5.177 | 21.291 | 942 | 0 | 0 | 0 | 0 | 4.815 |
| Total Income - EUR | 18.901 | 13.463 | 5.252 | 21.291 | 944 | 0 | 0 | 899 | 9.337 | 10.855 |
| Total Expenses - EUR | 22.976 | 18.821 | 11.611 | 20.499 | 7.075 | 1.121 | 844 | 1.399 | 10.078 | 12.693 |
| Gross Profit/Loss - EUR | -4.076 | -5.359 | -6.358 | 792 | -6.131 | -1.121 | -844 | -500 | -741 | -1.838 |
| Net Profit/Loss - EUR | -4.664 | -5.646 | -6.440 | 154 | -6.141 | -1.179 | -909 | -527 | -741 | -1.838 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Bio New Technology (B.n.t.) S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.260 | 917 | 631 | 1.853 | 1.263 | 1.239 | 1.211 | 1.132 | 1.128 | 1.122 |
| Current Assets | 28.287 | 14.787 | 16.783 | 13.467 | 15.296 | 14.605 | 14.281 | 14.863 | 27.425 | 39.997 |
| Inventories | 22.157 | 13.823 | 15.199 | 9.246 | 14.163 | 13.894 | 13.586 | 13.628 | 26.399 | 39.208 |
| Receivables | 4.570 | 827 | 882 | 823 | 1.033 | 711 | 695 | 697 | 694 | 705 |
| Cash | 1.560 | 136 | 702 | 3.398 | 101 | 0 | 0 | 538 | 332 | 84 |
| Shareholders Funds | -6.788 | -12.365 | -18.595 | -18.100 | -23.891 | -24.617 | -24.981 | -25.585 | -26.248 | -27.940 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 33.965 | 37.432 | 45.218 | 33.420 | 40.450 | 40.461 | 40.473 | 41.580 | 54.802 | 69.108 |
| Income in Advance | 2.370 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4321 - 4321" | |||||||||
| CAEN Financial Year |
4321
|
|||||||||
Comments - Bio New Technology (B.n.t.) S.r.l.